Exforge and Polaramine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Exforge (amlodipine besylate; valsartan) and Polaramine (dexchlorpheniramine maleate). Common drug interactions include general physical health deterioration among females and muscular weakness among males.

The phase IV clinical study analyzes what interactions people have when they take Exforge and Polaramine. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Exforge?

Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.

What is Polaramine?

Polaramine has active ingredients of dexchlorpheniramine maleate. It is often used in allergic rhinitis. eHealthMe is studying from 10,531 Polaramine users. Check the latest studies of Polaramine.

On Jul, 28, 2026

19 people who take Exforge and Polaramine together, and have interactions are studied.

Exforge and Polaramine drug interactions.

What are the common drug interactions of Exforge and Polaramine, by gender? *:

female:

General physical health deterioration (weak health status)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cardiac failure
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

male:

Muscular weakness (muscle weakness)
Pyrexia (fever)
Death
Pneumonia bacterial (pneumonia associated with bacterial infection)

What are the common drug interactions of Exforge and Polaramine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

General physical health deterioration (weak health status)

60+:

Muscular weakness (muscle weakness)
Pyrexia (fever)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cardiac failure
Death
Pneumonia bacterial (pneumonia associated with bacterial infection)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

What are the existing conditions these people have? *

High Blood Pressure: 16 people, 84.21%
High Blood Cholesterol: 10 people, 52.63%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 10 people, 52.63%
Anaemia (lack of blood): 9 people, 47.37%
Hypokalemia (low potassium): 8 people, 42.11%
Breast Cancer: 7 people, 36.84%
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 5 people, 26.32%
Multiple Myeloma (cancer of the plasma cells): 5 people, 26.32%
Diabetes: 5 people, 26.32%
Fever: 3 people, 15.79%

* Approximation only. Some reports may have incomplete information.

Do you take Exforge and Polaramine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously